|
DDX20 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.006800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.632200E-01 |
| Normal-vs-Stage2 |
5.607600E-01 |
| Normal-vs-Stage3 |
3.343200E-01 |
| Normal-vs-Stage4 |
3.468300E-02 |
| Stage1-vs-Stage2 |
1.995790E-01 |
| Stage1-vs-Stage3 |
2.756000E-02 |
| Stage1-vs-Stage4 |
1.280060E-03 |
| Stage2-vs-Stage3 |
9.525600E-01 |
| Stage2-vs-Stage4 |
3.932600E-01 |
| Stage3-vs-Stage4 |
2.522400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.147600E-01 |
| Normal-vs-AfricanAmerican |
4.440800E-01 |
| Normal-vs-Asian |
6.771600E-01 |
| Caucasian-vs-AfricanAmerican |
4.742800E-01 |
| Caucasian-vs-Asian |
6.942000E-01 |
| AfricanAmerican-vs-Asian |
5.326800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.309600E-01 |
| Normal-vs-Female |
1.716610E-01 |
| Male-vs-Female |
2.222300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.590800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.962000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.110400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.939000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.641800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.327800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.544200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.777600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.167200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.674600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.258620E-01 |
| Normal-vs-Grade 2 |
2.552200E-02 |
| Normal-vs-Grade 3 |
1.303750E-01 |
| Normal-vs-Grade 4 |
2.625700E-04 |
| Grade 1-vs-Grade 2 |
7.350600E-01 |
| Grade 1-vs-Grade 3 |
3.138300E-02 |
| Grade 1-vs-Grade 4 |
8.389500E-04 |
| Grade 2-vs-Grade 3 |
3.40840000001563E-06 |
| Grade 2-vs-Grade 4 |
1.11069997643654E-09 |
| Grade 3-vs-Grade 4 |
1.209580E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.208400E-04 |
| Normal-vs-ccB subtype |
6.119600E-03 |
| ccA subtype-vs-ccB subtype |
6.20037354792657E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.693200E-01 |
| Normal-vs-N1 |
1.258570E-01 |
| N0-vs-N1 |
2.696200E-01 |
|
|
